Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit.
Sepúlveda M, Llufriu S, Martínez-Hernández E, Català M, Artola M, Hernando A, Montejo C, Pulido-Valdeolivas I, Martínez-Heras E, Guasp M, Solana E, Llansó L, Escudero D, Aldea M, Prats C, Graus F, Blanco Y, Saiz A. Sepúlveda M, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 27;8(2):e954. doi: 10.1212/NXI.0000000000000954. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33504634 Free PMC article.
Metabolomic signatures associated with disease severity in multiple sclerosis.
Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A. Villoslada P, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28180139 Free PMC article.
Predictors of vision impairment in Multiple Sclerosis.
Sanchez-Dalmau B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, Llufriu S, Blanco Y, Sola-Valls N, Sepulveda M, Guerrero A, Alba S, Andorra M, Camos A, Sanchez-Vela L, Alfonso V, Saiz A, Villoslada P. Sanchez-Dalmau B, et al. PLoS One. 2018 Apr 17;13(4):e0195856. doi: 10.1371/journal.pone.0195856. eCollection 2018. PLoS One. 2018. PMID: 29664921 Free PMC article.
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
Andorra M, Nakamura K, Lampert EJ, Pulido-Valdeolivas I, Zubizarreta I, Llufriu S, Martinez-Heras E, Sola-Valls N, Sepulveda M, Tercero-Uribe A, Blanco Y, Saiz A, Villoslada P, Martinez-Lapiscina EH. Andorra M, et al. JAMA Neurol. 2018 Oct 1;75(10):1246-1255. doi: 10.1001/jamaneurol.2018.1596. JAMA Neurol. 2018. PMID: 29971335 Free PMC article.
Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.
Solà-Valls N, Vicente-Pascual M, Blanco Y, Solana E, Llufriu S, Martínez-Heras E, Martínez-Lapiscina EH, Sepúlveda M, Pulido-Valdeolivas I, Zubizarreta I, Saiz A. Solà-Valls N, et al. Mult Scler Relat Disord. 2019 Jan;27:333-339. doi: 10.1016/j.msard.2018.11.018. Epub 2018 Nov 19. Mult Scler Relat Disord. 2019. PMID: 30472411
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.
Zubizarreta I, Flórez-Grau G, Vila G, Cabezón R, España C, Andorra M, Saiz A, Llufriu S, Sepulveda M, Sola-Valls N, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Casanova B, Martinez Gines M, Tellez N, Oreja-Guevara C, Español M, Trias E, Cid J, Juan M, Lozano M, Blanco Y, Steinman L, Benitez-Ribas D, Villoslada P. Zubizarreta I, et al. Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8463-8470. doi: 10.1073/pnas.1820039116. Epub 2019 Apr 8. Proc Natl Acad Sci U S A. 2019. PMID: 30962374 Free PMC article. Clinical Trial.
Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.
Sepulveda M, Delgado-García G, Blanco Y, Sola-Valls N, Martinez-Lapiscina EH, Armangué T, Montejo C, Pulido-Valdeolivas I, Martinez-Hernandez E, Ariño H, Escudero D, Ruiz-García R, Llufriu S, Dalmau J, Graus F, Saiz A. Sepulveda M, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 30;6(6):e607. doi: 10.1212/NXI.0000000000000607. Print 2019 Nov. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31471461 Free PMC article.
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.
Andorrà M, Alba-Arbalat S, Camos-Carreras A, Gabilondo I, Fraga-Pumar E, Torres-Torres R, Pulido-Valdeolivas I, Tercero-Uribe AI, Guerrero-Zamora AM, Ortiz-Perez S, Zubizarreta I, Sola-Valls N, Llufriu S, Sepulveda M, Martinez-Hernandez E, Armangue T, Blanco Y, Villoslada P, Sanchez-Dalmau B, Saiz A, Martinez-Lapiscina EH. Andorrà M, et al. JAMA Neurol. 2020 Feb 1;77(2):234-244. doi: 10.1001/jamaneurol.2019.3283. JAMA Neurol. 2020. PMID: 31566686 Free PMC article.
42 results